MSD Dunboyne Biologics. The latest addition to the MSD Ireland family is MSD Dunboyne which joined our network in September 2020. Our Dunboyne site is MSD’s first Biologics Drug Substance Single Use Commercialization Facility, playing an important role in helping to commercialize key medicines as the newest addition to the MSD network. The cutting-edge innovation and collaboration between MSD Dunboyne’s research and manufacturing teams will significantly accelerate the time it takes to bring a medicine to market for the benefit of patients around the world.
Dave ConnollyHead of Manufacturing Science & Technology
Global Science Engineering & Commercialization email@example.com